中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2011

Effect of fenofibrate on hepatocyte apoptosis and hepatic glycogen in rats with obstructive jaundice

  • Published Date: 2011-09-20
  • Objective To investigate the effect of Fenofibrate on serum biochemical indicators, apoptosis and hepatic glycogen in rats with obstructive jaundice.Methods Rats were subjected to bile duct ligation to establish the cholestasis model.Forty-eight male Wistar rats were randomly divided into four groups equally: Group A = control group, Group B = bile duct ligation (BDL) , Group C = BDL + Fenofibrate (30 mg/kg daily) .Group D = BDL + Fenofibrate (60 mg/kg daily) .All rats were sacrificed on 7th day after obtaining blood samples and liver tissue.Serum ALT, AST, ALP, GGT, TBA were tested by automatic chemistry analyzer, the number of hepatocyte apoptosis were tested by TUNEL and hepatic glycogen were tested by PAS.Results Serum ALT, AST, ALP, GGT, TBA levels in rats with BDL were significantly higher than in the group A (P<0.001) .There was no significant difference in terms of serum ALT, AST, ALP, GGT, TBA levels between group B and group C.Serum ALT, AST, ALP, GGT, TBA levels in rats of group D were significantly lower than in group B, C (P<0.01) except ALT between Group D and Group C (P=0.021>0.01) .Hepatocyte apoptosis in rats with BDL were significantly higher than in the control group (P<0.001) .Hepatocyte apoptosis in the animals of group C were significantly lower than in group B (P=0.007<0.01) when hepatocyte apoptosis in group D were significantly lower than in group B or C (P=0.000<0.001) .Periodic acid schiff (PAS) reaction indicated that fenofibrate can strengthen hepatic glycogen synthesis in rats with obstructive jaundice.Conclusion Fenofibrate administration attenuates serum biochemical indicators、hepatocyte apoptosis and strengthen hepatic glycogen synthesis in rats with obstructive jaundice.

     

  • [1]许海波, 巩鹏.PPARs在梗阻性黄疸肝脏损伤中的作用[J].国际外科学杂志, 2007, 34 (7) :461-465.
    [2]Mehmet C, MustafaK, Tarkan K, et al.Peroxisome prolifera-tors-activated alpha agonist treatment ameliorates hepaticdamage in rats with obstructive jaundice:an experimentalstudy[J].BMC Gastroenterology, 2007, 7 (44) :1-7.
    [3]Lalloyer F, Staels B.Fibrates, glitazones, and peroxisomeproliferator-activated receptors[J].Arterioscler ThrombVasc Biol, 2010, 30 (5) :894-899.
    [4]Post SM, Duez H, Gervois PP, et al.Fibrates suppress bileacid synthesis viaperoxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol27-hydroxylase expression[J].Arte-rioscler Thromb Vasc Biol, 2001, 21 (11) :1840-1845.
    [5]Zollner G, Trauner M.Nuclear receptors as therapeutic tar-gets in cholestatic liver diseases[J].Br J Pharmacol, 2009, 156 (1) :7-27.
    [6]Trauner M, Meier PJ, Boyer JL.Molecular pathogenesis ofcholestasis[J].New Eng J Med, 1998, 339 (17) :1217-1227.
    [7]Aller MA, Arias JL, Prieto I, et al.Bile duct ligation:step-by-step to cholangiocyte inflammatory tumorigenesis[J].Eur J Gastroenterol Hepatol, 2010, 22 (6) :651-661.
    [8]Kobayashi A, Suzuki Y, Kuno H, et al.Effects of fenofibrateon plasma and hepatic transaminase activities and hepatictransaminase gene expression in rats[J].J Toxico Sci, 2009, 34 (4) :377-387.
    [9]张爱民, 徐德利, 徐峰, 等.梗阻性黄疸大鼠胆道引流时机对肝细胞凋亡的影响[J].肝胆外科杂志, 2008, 16 (5) :383-385.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2746) PDF downloads(677) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return